EPO and anemia: Our data also suggest that the anemia of CKD and the associated kidney hypoxia favour the development of fibrosis, angiogenesis and a local inflammatory milieu in the kidney that seem to underlie a “resistance” to EPO stimuli and reduced iron availability.